| Application no. and date | 18876779.2 (espacenet) (Federated) (European Patent Register), 20181111 | | Patent/reg. no. and date | DK/EP 3706739, 20241016 | | Publication date | 20200916 | | Priority no. and date | US 201762584856 P, 20171112, US 201862717948 P, 20180813 | | EP pub. no. and date |
EP 3706739 20200916 | | Effective date | | | Applicant/owner | Biohaven Therapeutics Ltd., 215 Church Street
New Haven, CT 06510, US | | Applicant ref. no. | PU282817DKQ | | Inventor | CORIC, Vladimir, 215 Church Street
New Haven
Connecticut 06510, US,
BERMAN, Robert, 215 Church Street
New Haven
Connecticut 06510, US,
BEINER, Melissa, 215 Church Street
New Haven
Connecticut 06510, US,
L'ITALIEN, Gilbert, 215 Church Street
New Haven
Connecticut 06510, US | | Representative | Marks & Clerk LLP, 44, rue de la Vallée
L-2661 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/427 (2006.01) , A61K 31/428 (2006.01) , A61K 31/4985 (2006.01) , A61K 9/20 (2006.01) , A61K 9/48 (2006.01) , A61P 25/14 (2006.01) , A61P 35/00 (2006.01) , C07D 277/82 (2006.01) , C07D 417/12 (2006.01) | | Title | ANVENDELSE AF RILUZOLPRODRUGS TIL BEHANDLING AF ATAKSIER | | Int. application no. | US2018060232 | | Int. publication no. | WO2019094851 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
